{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:00:18Z","timestamp":1792803618698,"version":"4.5.0"},"reference-count":37,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Hellenic Foundation for Research and Innovation (H.F.R.I.) under the H.F.R.I. PhD Fellowship grant","award":["Fellowship Number: 1338"],"award-info":[{"award-number":["Fellowship Number: 1338"]}],"id":[{"id":"https:\/\/ror.org\/05v75r592","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Targeted analytical methods for the determination of free fatty acids (FFAs) in human plasma are of high interest because they may help in identifying biomarkers for diseases and in monitoring the progress of a disease. The determination of FFAs is of particular importance in the case of metabolic disorders because FFAs have been associated with diabetes. We present a liquid chromatography-high resolution mass spectrometry (LC-HRMS) method, which allows the simultaneous determination of 74 FFAs in human plasma. The method is fast (10-min run) and straightforward, avoiding any derivatization step and tedious sample preparation. A total of 35 standard saturated and unsaturated FFAs, as well as 39 oxygenated (either hydroxy or oxo) saturated FFAs, were simultaneously detected and quantified in plasma samples from 29 subjects with type 2 diabetes mellitus (T2D), 14 with type 1 diabetes mellitus (T1D), and 28 healthy subjects. Alterations in the levels of medium-chain FFAs (C6:0 to C10:0) were observed between the control group and T2D and T1D patients.<\/jats:p>","DOI":"10.3390\/biomedicines10051189","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T13:56:12Z","timestamp":1653054972000},"page":"1189","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Lipidomics Analysis of Free Fatty Acids in Human Plasma of Healthy and Diabetic Subjects by Liquid Chromatography-High Resolution Mass Spectrometry (LC-HRMS)"],"prefix":"10.3390","volume":"10","author":[{"given":"Maroula G.","family":"Kokotou","sequence":"first","affiliation":[{"name":"Department of Chemistry, National and Kapodistrian University of Athens, 15771 Athens, Greece"},{"name":"Laboratory of Chemistry, Department of Food Science and Human Nutrition, Agricultural University of Athens, Iera Odos 75, 11855 Athens, Greece"},{"name":"Center of Excellence for Drug Design and Discovery, National and Kapodistrian University of Athens, 15771 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2621-1231","authenticated-orcid":false,"given":"Christiana","family":"Mantzourani","sequence":"additional","affiliation":[{"name":"Department of Chemistry, National and Kapodistrian University of Athens, 15771 Athens, Greece"},{"name":"Center of Excellence for Drug Design and Discovery, National and Kapodistrian University of Athens, 15771 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charikleia S.","family":"Batsika","sequence":"additional","affiliation":[{"name":"Department of Chemistry, National and Kapodistrian University of Athens, 15771 Athens, Greece"},{"name":"Center of Excellence for Drug Design and Discovery, National and Kapodistrian University of Athens, 15771 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga G.","family":"Mountanea","sequence":"additional","affiliation":[{"name":"Department of Chemistry, National and Kapodistrian University of Athens, 15771 Athens, Greece"},{"name":"Center of Excellence for Drug Design and Discovery, National and Kapodistrian University of Athens, 15771 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Eleftheriadou","sequence":"additional","affiliation":[{"name":"Center of Excellence for Drug Design and Discovery, National and Kapodistrian University of Athens, 15771 Athens, Greece"},{"name":"Diabetes Center, First Department of Propaedeutic and Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, 15772 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ourania","family":"Kosta","sequence":"additional","affiliation":[{"name":"Diabetes Center, First Department of Propaedeutic and Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, 15772 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0615-2534","authenticated-orcid":false,"given":"Nikolaos","family":"Tentolouris","sequence":"additional","affiliation":[{"name":"Center of Excellence for Drug Design and Discovery, National and Kapodistrian University of Athens, 15771 Athens, Greece"},{"name":"Diabetes Center, First Department of Propaedeutic and Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, 15772 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3753-7082","authenticated-orcid":false,"given":"George","family":"Kokotos","sequence":"additional","affiliation":[{"name":"Department of Chemistry, National and Kapodistrian University of Athens, 15771 Athens, Greece"},{"name":"Center of Excellence for Drug Design and Discovery, National and Kapodistrian University of Athens, 15771 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,20]]},"reference":[{"key":"ref_1","unstructured":"Calder, P.C., and Burdge, G.C. (2004). Fatty Acids in Bioactive Lipids, The Oily Press."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3945\/an.111.001602","article-title":"Mechanisms of Gene Regulation by Fatty Acids","volume":"3","author":"Georgiadi","year":"2012","journal-title":"Adv. Nutr."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1152\/physrev.00041.2018","article-title":"Free Fatty Acid Receptors in Health and Disease","volume":"100","author":"Kimura","year":"2020","journal-title":"Physiol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/med.21441","article-title":"Free Fatty Acid Receptor 1 (FFAR1) as an Emerging Therapeutic Target for Type 2 Diabetes Mellitus: Recent Progress and Prevailing Challenges","volume":"38","author":"Li","year":"2018","journal-title":"Med. Res. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev-nutr-071714-034410","article-title":"Dietary fatty acids and their potential for controlling metabolic diseases through activation of FFA4\/GPR120","volume":"35","author":"Ulven","year":"2015","journal-title":"Annu. Rev. Nutr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41574-020-00459-w","article-title":"Targeting lipid GPCRs to treat type 2 diabetes mellitus\u2014Progress and challenges","volume":"17","author":"Ghislain","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coemr.2020.06.005","article-title":"Metabolic and inflammatory functions of short-chain fatty acid receptors","volume":"16","author":"Bolognini","year":"2021","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1464-5491.2007.02186.x","article-title":"The importance of free fatty acids in the development of Type 2 diabetes","volume":"24","author":"Wilding","year":"2007","journal-title":"Diabet. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/MED.0b013e3283444b09","article-title":"Obesity, insulin resistance and free fatty acids","volume":"18","author":"Boden","year":"2011","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Sobczak, A.I.S., Blindauer, C.A., and Stewart, A.J. (2019). Changes in plasma free fatty acids associated with type-2 diabetes. Nutrients, 11.","DOI":"10.3390\/nu11092022"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2337\/diab.37.8.1020","article-title":"Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1053\/meta.2002.35202","article-title":"The role of plasma fatty acid composition in endogenous glucose production in patients with type 2 diabetes mellitus","volume":"51","author":"Clore","year":"2002","journal-title":"Metabolism"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.chemphyslip.2007.08.002","article-title":"Simultaneously quantitative measurement of comprehensive profiles of esterified and non-esterified fatty acid in plasma of type 2 diabetic patients","volume":"150","author":"Yi","year":"2007","journal-title":"Chem. Phys. Lipids"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1016\/j.jchromb.2010.08.035","article-title":"Free fatty acid metabolic profile and biomarkers of isolated post-challenge diabetes and type 2 diabetes mellitus based on GC\u2013MS and multivariate statistical analysis","volume":"878","author":"Liu","year":"2010","journal-title":"J. Chromatogr. B"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Grapov, D., Adams, S.H., Pedersen, T.L., Garvey, W.T., and Newman, J.W. (2012). Type 2 Diabetes Associated Changes in the Plasma Non-Esterified Fatty Acids, Oxylipins and Endocannabinoids. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0048852"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1007\/s00125-016-4069-2","article-title":"Metabolic signatures and risk of type 2 diabetes in a Chinese population: An untargeted metabolomics study using both LC-MS and GC-MS","volume":"59","author":"Lu","year":"2016","journal-title":"Diabetologia"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1055\/s-0043-121263","article-title":"Plasma Free Fatty Acids Metabolic Profile Among Uyghurs and Kazaks With or Without Type 2 Diabetes Based on GC-MS","volume":"126","author":"Ma","year":"2018","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"12666","DOI":"10.1021\/acs.jmedchem.0c00844","article-title":"Saturated Hydroxy Fatty Acids Exhibit a Cell Growth Inhibitory Activity and Suppress the Cytokine-Induced \u03b2-Cell Apoptosis","volume":"63","author":"Kokotou","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1021\/acs.jmedchem.0c02058","article-title":"Saturated Oxo Fatty Acids (SOFAs): A Previously Unrecognized Class of Endogenous Bioactive Lipids Exhibiting a Cell Growth Inhibitory Activity","volume":"64","author":"Batsika","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Kokotou, M.G., Mantzourani, C., Bourboula, A., Mountanea, O.G., and Kokotos, G. (2020). A Liquid Chromatography-High Resolution Mass Spectrometry (LC-HRMS) Method for the Determination of Free Hydroxy Fatty Acids in Cow and Goat Milk. Molecules, 25.","DOI":"10.3390\/molecules25173947"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Kokotou, M.G., Batsika, C.S., Mantzourani, C., and Kokotos, G. (2021). Free Saturated Oxo Fatty Acids (SOFAs) and Ricinoleic Acid in Milk Determined by a Liquid Chromatography-High-Resolution Mass Spectrometry (LC-HRMS) Method. Metabolites, 11.","DOI":"10.3390\/metabo11010046"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"14528","DOI":"10.1021\/acs.analchem.0c02719","article-title":"In-Depth Annotation Strategy of Saturated Hydroxy Fatty Acids Based on Their Chromatographic Retention Behaviors and MS Fragmentation Patterns","volume":"92","author":"Zhu","year":"2020","journal-title":"Anal. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-1-4939-7057-5_14","article-title":"High-Throughput Quantitative Lipidomics Analysis of Nonesterified Fatty Acids in Plasma by LC-MS","volume":"Volume 1619","author":"Christinat","year":"2017","journal-title":"Serum\/Plasma Proteomics"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Kokotou, M.G., Mantzourani, C., and Kokotos, G. (2020). Development of a Liquid Chromatography\u2013High Resolution Mass Spectrometry Method for the Determination of Free Fatty Acids in Milk. Molecules, 25.","DOI":"10.3390\/molecules25071548"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1017\/S0007114515004341","article-title":"Impact of methods used to express levels of circulating fatty acids on the degree and direction of associations with blood lipids in humans","volume":"115","author":"Sergeant","year":"2016","journal-title":"Br. J. Nutr."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/clinchem\/44.3.463","article-title":"Simultaneous analysis of plasma free fatty acids and their 3-hydroxy analogs in fatty acid beta-oxidation disorders","volume":"44","author":"Costa","year":"1998","journal-title":"Clin. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1177\/0004563218801393","article-title":"Determination of total, free and esterified short-chain fatty acid in human serum by liquid chromatography-mass spectrometry","volume":"56","author":"Chen","year":"2018","journal-title":"Ann. Clin. Biochem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1194\/jlr.M009449","article-title":"Lipidomics reveals a remarkable diversity of lipids in human plasma","volume":"51","author":"Quehenberger","year":"2010","journal-title":"J. Lipid Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/bmc.3251","article-title":"Simultaneous analysis of seven 2-hydroxy fatty acids as tert-butyldimethylsilyl derivatives in plasma by gas chromatography-mass spectrometry","volume":"29","author":"Seo","year":"2015","journal-title":"Biomed. Chromatogr."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cell.2014.09.035","article-title":"Discovery of a Class of Endogenous Mammalian Lipids with Anti-Diabetic and Anti-inflammatory Effects","volume":"159","author":"Yore","year":"2014","journal-title":"Cell"},{"key":"ref_31","first-page":"405","article-title":"Fatty acid 2-Hydroxylation in mammalian sphingolipid biology","volume":"1801","author":"Hama","year":"2010","journal-title":"Biochim. Biophys. Acta (BBA) Mol. Cell Biol. Lipids"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.immuni.2016.04.006","article-title":"Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine","volume":"44","author":"Haghikia","year":"2016","journal-title":"Immunity"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3389\/fimmu.2020.01390","article-title":"Alterations in Circulating Fatty Acid Are Associated With Gut Microbiota Dysbiosis and Inflammation in Multiple Sclerosis","volume":"11","author":"Saresella","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5551\/jat.42945","article-title":"Identification of Metabolites Associated with Onset of CAD in Diabetic Patients Using CE-MS Analysis: A Pilot Study","volume":"26","author":"Omori","year":"2019","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Suhre, K., Meisinger, C., D\u00f6ring, A., Altmaier, E., Belcredi, P., Gieger, C., Chang, D., Milburn, M.V., Gall, W.E., and Weinberger, K.M. (2010). Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological Setting. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0013953"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.2337\/db13-0570","article-title":"Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach","volume":"62","author":"Menni","year":"2013","journal-title":"Diabetes"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.plipres.2015.07.002","article-title":"Should the pharmacological actions of dietary fatty acids in cardiometabolic disorders be classified based on biological or chemical function?","volume":"59","author":"Poudyal","year":"2015","journal-title":"Prog. Lipid Res."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/5\/1189\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:15:44Z","timestamp":1760138144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/5\/1189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,20]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["biomedicines10051189"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10051189","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,20]]}}}